- Corporate Officers - S
- Soni Manmeet Singh
Insider Trading History of Soni Manmeet Singh
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Soni Manmeet Singh since 2014.
This trader's CIK number is 1569769.
At the time of last reporting, Soni Manmeet Singh was the Chief Operating Officer of Summit Therapeutics Inc.. (stock ticker symbol SMMT).
Also see all insider trading activities at Summit Therapeutics Inc..
Note that in the past
Soni Manmeet Singh also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Soni Manmeet Singh
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | PCYC | 0 | $0 | 27,514 | $6,995,234 | 24,098 | $1,917,550 |
| 2014 | PCYC | 0 | $0 | 1,000 | $141,442 | 1,000 | $61,600 |
Yearly summary of insider trading at Arena Pharmaceuticals Inc (ARNA) by Soni Manmeet Singh
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ARNA | 0 | $0 | 1,631 | $98,851 | 0 | $0 |
| 2019 | ARNA | 0 | $0 | 1,217 | $68,351 | 0 | $0 |
Yearly summary of insider trading at Reata Pharmaceuticals Inc (RETA) by Soni Manmeet Singh
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | RETA | 0 | $0 | 184,137 | $23,095,081 | 25,000 | $683,000 |
| 2021 | RETA | 16,000 | $419,568 | 0 | $0 | 0 | $0 |
| 2020 | RETA | 3,000 | $300,615 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Summit Therapeutics Inc. (SMMT) by Soni Manmeet Singh
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | SMMT | 2,976,190 | $4,999,999 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Soni Manmeet Singh:
1. Pharmacyclics Inc (PCYC)
2. Arena Pharmaceuticals Inc (ARNA)
3. Reata Pharmaceuticals Inc (RETA)
4. Summit Therapeutics Inc. (SMMT)
Table 1. Insider trading of Pharmacyclics Inc (PCYC) by Soni Manmeet Singh
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-11 | PCYC | Sale | 24,098 | 254.15 | 6,124,506 |
| 2015-03-13 | PCYC | Sale | 3,416 | 254.90 | 870,728 |
| 2015-03-11 | PCYC | Option Ex | 24,098 | 79.57 | 1,917,550 |
| 2014-11-13 | PCYC | Option Ex | 1,000 | 61.60 | 61,600 |
| 2014-11-13 | PCYC | Sale | 1,000 | 141.44 | 141,442 |
Table 2. Insider trading of Arena Pharmaceuticals Inc (ARNA) by Soni Manmeet Singh
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-17 | ARNA | Sale | 304 | 62.74 | 19,072 |
| 2020-06-15 | ARNA | Sale | 1,327 | 60.12 | 79,779 |
| 2019-06-14 | ARNA | Sale | 1,217 | 56.16 | 68,351 |
Table 3. Insider trading of Reata Pharmaceuticals Inc (RETA) by Soni Manmeet Singh
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-28 | RETA | Sale | 75,000 | 164.62 | 12,346,275 |
| 2023-06-13 | RETA | Option Ex | 25,000 | 27.32 | 683,000 |
| 2023-06-12 | RETA | Sale | 4,711 | 99.62 | 469,295 |
| 2023-06-13 | RETA | Sale | 78,085 | 102.89 | 8,033,853 |
| 2023-05-15 | RETA | Sale | 21,507 | 84.94 | 1,826,847 |
| 2023-05-16 | RETA | Sale | 625 | 80.93 | 50,583 |
| 2023-03-07 | RETA | Sale | 622 | 84.69 | 52,680 |
| 2023-03-03 | RETA | Sale | 3,587 | 87.97 | 315,548 |
| 2021-12-31 | RETA | Buy | 16,000 | 26.22 | 419,568 |
| 2020-08-14 | RETA | Buy | 3,000 | 100.20 | 300,615 |
Table 4. Insider trading of Summit Therapeutics Inc. (SMMT) by Soni Manmeet Singh
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-10-13 | SMMT | Buy | 2,976,190 | 1.68 | 4,999,999 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Soni Manmeet Singh
(Chief Operating Officer of Summit Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.